Our mission is to provide solutions for enterprise's resistance improving, when "attack" risk factor. Our conception based on two research issues.
First, identification of the elements that constitute corporate immune system. The latter is responsible for coping with risk. The question is: how to compensate risk? In other words: how to adjust corporate response to risk (antigen). What should be done to ensure desirable response when the risk factor attacks.. The problem can be defined as bringing risk factors under control by using elements of immunology.
Second, development of the research method using the approach of medical examination of a patient. It embraces three phases: diagnosis, therapy, prevention.
For more info contact us: email@example.com .